PharmDr. Krejsta

Chief Executive Officer at LEXUM a.s./ Chairman of the Board of Directors at SAPOCH, z.s./ Executive at AVEL CZ, AVEL SK associations

Dr. Michal Krejsta, MBA, is a highly accomplished Senior Executive Leader with a vast CEO and Chairman of the Board of Directors experience in the pharmaceutical and healthcare industry.

He has a strong focus on Market Access and Corporate Affairs, building relationships with state regulators, healthcare payers, and providers to drive business results, commercial excellence, and innovation.

Dr. Krejsta holds multiple advanced degrees, including a Master's Degree in Pharmacy, PharmDr., LL.M. in International Law, Master in Healthcare Management, Master in Commercial Excellence, and an Executive MBA from The Nottingham Trent University.

Throughout his career, he has held key leadership positions in renowned organizations such as AstraZeneca, Pfizer, Omega Pharma, Phoenix, Celesio, and Penta Investments.

He has served as Chairman of the Board of Directors of various associations, including Sdružení ambulantních poskytovatelů oční chirurgie (SAPOCH, z.s.) and ČAFF Czech Association of Pharmaceutical Producers.

His vast experience includes roles such as Chief Executive Officer, Executive Secretary, General Manager, Commercial Director, Sales Director, and Marketing Manager at esteemed companies like Omega Pharma, Pfizer, Bayer, and AstraZeneca.